NEW YORK, Jan. 5, 2018 /PRNewswire/ -- Read the full report: https://www.reportlinker.com/p04534881
The interventional cardiology devices market is expected to reach USD 20.85 billion by 2022 from USD 14.52 billion in 2017, at a CAGR of 7.5%. Factors driving the growth of this market include rising geriatric population, improving healthcare infrastructure, and increasing incidence of CVD. On the other hand, the stringent regulatory scenario for these devices and the availability of effective first-line treatments is expected to limit market growth in the coming years The plaque modification devices segment is anticipated to grow at the fastest rate during the forecast period.
The plaque modification devices market, by type, is categorized into thrombectomy devices and atherectomy devices. The thrombectomy devices segment is estimated to grow at the fastest rate during the forecast period. The increasing demand for technologically advanced thrombectomy devices is a key factor driving the growth of this market The angioplasty stents segment is estimated to hold the largest market share during the forecast period.
The angioplasty stents market is segmented drug-eluting stents, bare-metal stents, and bioresorbable stents. The bioresorbable stents segment is the fastest-growing segment of the global angioplasty stents market. Technological advancement in stents is driving the growth of this segment. Asia Pacific is estimated to grow at the highest CAGR during the study period. Geographically, the interventional cardiology devices market is dominated by North America, followed by Europe in 2017. Asia Pacific is estimated to grow at the fastest rate, due to infrastructural development in its healthcare systems, the rising burden of CVD, and increasing healthcare expenditure in APAC countries. The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1–43%, Tier 2–35%, and Tier 3–22% • By Designation: C level–53%, Director level–32%, Others–15% • By Region: North America–32%, Europe–24%, Asia Pacific–21%, Latin America–12%, Middle East and Africa–11% The key players in the interventional cardiology devices market include Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), Terumo (Japan), Cordis (US), B. Braun (Germany), C.R. Bard (US), Biosensors (Singapore), and BIOTRONIK (Germany). Research Coverage:
The report analyses the interventional cardiology devices market by type and region. Apart from a comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players over the last three years. In addition, the company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of the future trends will help key market players and new entrants make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful. Key Benefits of Buying the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report can use one or a combination of the below mentioned five strategies for strengthening their market shares. The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the interventional cardiology devices market • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the interventional cardiology devices market • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the interventional cardiology devices market • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various tissue diagnostics products and services across geographies • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the interventional cardiology devices marketRead the full report: https://www.reportlinker.com/p04534881
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001
Advertisement
View original content:http://www.prnewswire.com/news-releases/the-interventional-cardiology-devices-market-is-expected-to-reach-usd-2085-billion-by-2022-from-usd-1452-billion-in-2017-at-a-cagr-of-75-300578169.html
SOURCE Reportlinker
